---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-25-001008"
form_type: "8-K"
ticker: "IMUX"
cik: "0001280776"
company_name: "IMMUNIC, INC."
filed_at: "2025-07-11T23:59:59+00:00"
generated_at: "2026-05-18T06:53:16.673858+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Immunic grants 35M stock appreciation rights to employees and executives at $0.77 strike

## Summary
- Company authorized up to 35M SARs for employees and exec officers; 22,015,000 to exec officers.
- Exercise price of $0.77 (July 7 closing); settlement in shares subject to shareholder approval to increase plan shares.
- 5M SARs exercisable Aug 1, 2026; 30M contingent on warrant exercises and private placement tranches from Jan 2024 offering.
- Company intends to seek stockholder approval to amend 2019 Omnibus Equity Incentive Plan to increase authorized shares.

## SEC filing metadata
- accession: 0001193805-25-001008
- form_type: 8-K
- ticker: IMUX
- cik: 0001280776
- company_name: IMMUNIC, INC.
- filed_at: 2025-07-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1280776/000119380525001008/0001193805-25-001008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1280776/000119380525001008/e664690_8k-immunic.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-25-001008
- JSON: https://secwatch.observer/filing/0001193805-25-001008.json
- Plain text: https://secwatch.observer/filing/0001193805-25-001008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.